The corporation will pay $200 per share for Prometheus Biosciences through one of its subsidiaries. Merck & Co has agreed to buy Prometheus Biosciences Inc for roughly $10.8 billion to expand its immunological business, the firms announced...
As a component of the National Institutes of Health (NIH), the National Cancer Institute (NCI) has assisted in the beginning of a phase 3 randomised clinical trial (NCT05633602) evaluating a two-drug combination for the treatment of patients with...
The agreement between ProBioGen and ImmunOs Therapeutics has been extended in order to continue producing clinical materials on a wide scale for IOS-1002, ImmunOs' main initiative for the treatment of cancer. For the novel biologic created by...
To offer medical expense loans of up to Rs. 10 lacs for all elective treatments on free EMI under their CareNow PayLater proposition, Fibe (previously EarlySalary), one of India's top consumer lending platforms, has partnered with Pristyn Care...
The AB-rated generic version of the trademarked product Combigan, Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, was just released, according to Upsher-Smith Laboratories, LLC (Upsher-Smith). A collaborative cooperation...
Henry Ford Health, a not-for-profit healthcare organisation in the Detroit metro region, and Illumina Inc., a world leader in DNA sequencing and array-based technologies, have announced the beginning of a cooperation to examine the effects of...
.jpg)
Medical devices are playing a key role in the healthcare ecosystem and provide innovative solutions for improvement of the patient health conditions.
With a target price of Rs 1029.8, ICICI Direct has acquired a call on Sun Pharmaceutical Industries. Sun Pharmaceutical Industries is currently trading at Rs 1010. ICICI Direct advised keeping the stop loss at Rs 1006.3...
Rare diseases are described as potentially fatal or persistently debilitating conditions that affect a limited number of people. Novartis committed around $10 billion on total research and development (R&D) in 2022 and has already received 23...
Lupin Limited (Lupin) announced the opening of a new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of its diagnostics network expansion. The establishment of the new laboratory is a significant step forward in...
, CDSCO.jpg)
